Editorial Policies
- Conflict of Interest and Financial Disclosures (specific to editors)
- Creative Commons License
- COPE Recommendation for Plagiarism
- Publication Ethics and Malpractice Statement
- Peer Review Process
- COPE Recommendation for Conflict of Interest (specific to editors)
- Editorial Policies
- Publisher Policies
- Editorial Process
- Advertisement Policies
Conflict of Interest and Financial Disclosures (specific to editors)
Editors of Clinical Trials and Practice – Open Journal are required to disclose any potential conflicts of interest (COI) that may influence their impartiality during the editorial process. A COI may arise from financial, professional, or personal relationships with authors, institutions, or sponsors. Editors must complete a COI disclosure form before assuming their editorial duties and update this disclosure if any new conflicts arise during their tenure. If an editor has a COI with a particular manuscript, they are expected to recuse themselves from handling the review and decision-making process for that manuscript. The journal strives to maintain a fair and unbiased editorial process, ensuring that decisions are based solely on the quality and scientific merit of the work. Additionally, any financial or other relationships that could appear to affect the editorial judgment of an editor must be declared, including but not limited to funding, consultancy, or investments in related research areas. The journal adheres to the Committee on Publication Ethics (COPE) guidelines in managing conflicts of interest to maintain the credibility and integrity of the editorial process.
Creative Commons License
Clinical Trials and Practice – Open Journal publishes all articles under a Creative Commons Attribution (CC BY) license. This open-access licensing model allows others to freely share, adapt, and build upon the work, provided proper credit is given to the original authors. The CC BY license ensures that research is accessible without financial barriers, enabling maximum dissemination and reuse of scientific findings. Authors retain copyright over their work but grant the journal the right to distribute the article under this license, facilitating wider reach and engagement with the scientific community. The Creative Commons model also supports transparency, collaboration, and the free exchange of knowledge. By choosing a CC BY license, Clinical Trials and Practice – Open Journal promotes open science and the global sharing of research, contributing to the acceleration of innovation and fostering greater academic collaboration. Authors are encouraged to share their articles with academic platforms, repositories, and social media to increase visibility and citation. This policy is in line with the journal’s commitment to open access and ensuring that high-quality research reaches as many readers as possible, regardless of subscription barriers.
COPE Recommendation for Plagiarism
In accordance with the guidelines set by the Committee on Publication Ethics (COPE), Clinical Trials and Practice – Open Journal has a strict policy against plagiarism. All manuscripts submitted to the journal undergo plagiarism detection using advanced software to identify any content that may have been copied or improperly attributed. If plagiarism is detected, the manuscript is immediately rejected, and the authors are notified of the violation. The journal adheres to COPE’s recommendations for handling plagiarism, which may include providing the author with an opportunity to correct or retract the manuscript if the issue is identified post-publication. Authors are required to properly attribute all sources, including text, data, and figures, and to ensure that their work is original. If plagiarism is identified after publication, Clinical Trials and Practice – Open Journal will take corrective actions, including issuing retractions or corrections where necessary. The journal aims to maintain high ethical standards and academic integrity, ensuring that all research is free from unethical practices like plagiarism. The COPE guidelines are used as the standard to guide editorial decisions on plagiarism and other ethical issues in publishing.
Publication Ethics and Malpractice Statement
Clinical Trials and Practice – Open Journal adheres to a rigorous publication ethics and malpractice policy, in line with the Committee on Publication Ethics (COPE) guidelines. The journal is committed to upholding the highest standards of research integrity, ensuring that all published content is original, ethically conducted, and transparent. Authors are required to declare any conflicts of interest, financial support, and ethical approval for human and animal studies. The journal also expects authors to avoid plagiarism, data fabrication, or manipulation. Editors are responsible for ensuring that manuscripts are reviewed fairly, impartially, and with respect for confidentiality. In cases of misconduct, such as plagiarism, duplicate publication, or unethical research practices, the journal reserves the right to reject submissions and retract articles. All allegations of research misconduct are thoroughly investigated, and authors and reviewers are expected to cooperate in the resolution of any disputes. The journal encourages responsible authorship practices, where all contributors are appropriately credited and all necessary permissions for data and images are obtained. The ethical standards set forth in this policy ensure that Clinical Trials and Practice – Open Journal remains a trusted source of high-quality, credible research.
Peer Review Process
Clinical Trials and Practice – Open Journal employs a double-blind peer review process to ensure the impartial evaluation of manuscripts. Both the authors’ identities and the reviewers’ identities are concealed during the review process to prevent bias. Once a manuscript is submitted, the editorial team conducts an initial assessment to verify that it meets the journal’s scope and quality standards. If the manuscript passes this stage, it is sent to two or more independent experts in the field for peer review. Reviewers assess the manuscript for scientific rigor, originality, methodology, and clarity of presentation. They provide detailed feedback, including suggestions for improvement. The final decision on whether a manuscript is accepted, revised, or rejected is made by the editorial team, taking into account the reviewers’ comments. Authors are provided with reviewers’ feedback and may be asked to make revisions to address concerns or improve the manuscript. The peer review process is designed to maintain high academic standards and ensure that only scientifically sound and ethically responsible research is published. The journal strives to ensure transparency and fairness in its review process, following the best practices outlined by the Committee on Publication Ethics (COPE).
COPE Recommendation for Conflict of Interest (specific to editors)
Clinical Trials and Practice – Open Journal follows the COPE (Committee on Publication Ethics) guidelines for managing conflicts of interest (COI) for editors. Editors must disclose any financial, personal, or professional interests that could influence their editorial decisions. This includes any relationships with the authors, institutions, or organizations involved in the manuscript under consideration. Editors are required to recuse themselves from handling manuscripts where they have a COI, ensuring that decisions are made based on merit alone. The journal’s editorial team is committed to transparency and fairness in the publication process, preventing any undue influence on manuscript selection. If a COI arises during the editorial process, the journal ensures that the manuscript is reassigned to another editor or handled according to COPE’s recommendations. This helps maintain the integrity of the journal and ensures that the review and publication decisions are objective and unbiased. By adhering to COPE’s conflict-of-interest guidelines, Clinical Trials and Practice – Open Journal fosters a trustworthy and transparent editorial process, ensuring that the research published in the journal meets the highest ethical standards.
Editorial Policies
Clinical Trials and Practice – Open Journal maintains a set of editorial policies designed to ensure the integrity, transparency, and quality of the publication process. These policies cover manuscript submission, peer review, publication ethics, and authorship guidelines. The journal’s editorial policies are aligned with international standards and best practices, such as those set by the Committee on Publication Ethics (COPE). All submitted manuscripts undergo a thorough peer review process to ensure scientific quality, originality, and relevance. Editors are responsible for ensuring that the journal’s content is consistent with its scope and that all published research meets the highest standards of scientific rigor. Authors are required to follow the submission guidelines, which include proper formatting, ethical disclosures, and compliance with the journal’s plagiarism policy. The journal also adheres to policies on conflicts of interest, ensuring that editorial decisions are free from bias. The editorial team is committed to maintaining the highest level of integrity in the peer review and publication process, ensuring that only credible, high-quality research is published.
Publisher Policies
The publisher of Clinical Trials and Practice – Open Journal adheres to strict publishing policies that promote high ethical standards, transparency, and the dissemination of high-quality research. These policies are designed to ensure that authors, reviewers, and editors comply with ethical guidelines set by international organizations such as the Committee on Publication Ethics (COPE). The publisher is committed to maintaining transparency in the editorial process, ensuring that authors’ rights are respected, and promoting open access for all articles. The publisher also supports ethical research practices, including the responsible reporting of research results and the protection of participant privacy. The publisher provides resources for authors, including guidelines for manuscript preparation and ethical compliance. Additionally, the publisher ensures the integrity of the peer review process, using tools for plagiarism detection and safeguarding against conflicts of interest. All published articles are made freely available online, in line with the journal’s open-access model. The publisher is committed to maintaining the highest standards in scientific publishing and ensuring that all stakeholders in the publication process—authors, reviewers, editors, and readers—can trust the content of the journal.
Editorial Process
Clinical Trials and Practice – Open Journal follows a systematic and transparent editorial process to ensure that the peer review and publication of articles are fair, efficient, and of high scientific quality. Once a manuscript is submitted, it undergoes an initial review by the editorial team to assess its relevance and quality. If the manuscript meets the journal’s criteria, it is sent to multiple expert reviewers who provide constructive feedback. The editorial team makes the final decision based on the reviewers’ comments and the manuscript’s adherence to the journal’s standards. Authors are given the opportunity to revise their manuscripts in response to reviewer feedback, ensuring that all concerns are addressed before publication. The journal’s editorial process is designed to be rigorous and fair, providing authors with transparent feedback while ensuring that only research of the highest quality is published. The process is fully aligned with the guidelines of the Committee on Publication Ethics (COPE), ensuring the integrity of the journal and the research it publishes.
Advertisement Policies
Clinical Trials and Practice – Open Journal adheres to a strict advertising policy to maintain the integrity and independence of its content. Advertisements in the journal must be clearly distinguished from editorial content and should not influence or appear to influence the editorial decisions. The journal does not accept advertisements that promote products, services, or research practices that may compromise the ethical standards or scientific rigor of the journal. Advertisements must comply with legal and ethical standards, and the editorial team retains the right to reject any advertisement that is deemed inappropriate or misleading. Advertisements are limited to relevant and reputable products or services related to clinical trials, medical research, and other scientific fields. The journal is committed to maintaining transparency and ensuring that advertising does not compromise the editorial independence of the journal.
